Brain metastases and immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis

被引:0
|
作者
Haizhu Chen
Yu Feng
Yu Zhou
Yunxia Tao
Le Tang
Yuankai Shi
机构
[1] Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs,Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical
来源
关键词
Non-small cell lung cancer; Immune checkpoint inhibitor; Brain metastases; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3071 / 3085
页数:14
相关论文
共 50 条
  • [31] Immune checkpoint inhibitors with or without radiotherapy in metastatic non-small cell lung cancer: A meta-analysis and literature review
    Danbala, Isah Adamu
    Fu, Shengqiao
    Sheng, Wanying
    Tang, Haowen
    Magashi, Mahmud Abdulkadir
    Wang, Xu
    ONCOLOGY LETTERS, 2024, 28 (04)
  • [32] Sarcopenia as a Determinant of the Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: A Meta-Analysis
    Ren, Bixin
    Shen, Jiucheng
    Qian, Yajuan
    Zhou, Tong
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2023, 75 (02): : 685 - 695
  • [33] Assessing the Relationship Between Liver Metastases and the Survival of Patients With Non-Small Cell Lung Cancer After Immune Checkpoint Inhibitors Treatment: A Systematic Review and Meta-Analysis
    Xu, Huilin
    Ming, Pingpo
    Zhao, Zhenyu
    Zhao, Nan
    Zhou, Dingjie
    Tang, Xixian
    Cao, Dedong
    INTEGRATIVE CANCER THERAPIES, 2023, 22
  • [34] Efficacy and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer: A systematic review and meta-analysis
    Feng, Yu
    Tao, Yunxia
    Chen, Haizhu
    Zhou, Yu
    Tang, Le
    Liu, Chenwei
    Hu, Xingsheng
    Shi, Yuankai
    THORACIC CANCER, 2023, 14 (25) : 2536 - 2547
  • [35] Endocrine Dysfunction of Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Yang, F.
    Lin, L.
    Chen, X.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [36] Association of clinical and molecular factors with immune checkpoint inhibitors efficacy in advanced non-small cell lung cancer:A systematic review and meta-analysis
    Li, F.
    Lv, Z.
    Mao, Y.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1054 - S1054
  • [37] Impact of bone metastasis on the prognosis of non-small cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
    Lina Liu
    Zhongyi Shi
    Xingdong Qiu
    Clinical and Translational Oncology, 2024, 26 : 747 - 755
  • [38] Association of clinical and molecular factors with immune checkpoint inhibitors efficacy in advanced non-small cell lung cancer: A systematic review and meta-analysis
    Li, F.
    Lv, Z.
    Mao, Y.
    ANNALS OF ONCOLOGY, 2022, 33 : S1574 - S1575
  • [39] Impact of bone metastasis on the prognosis of non-small cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
    Liu, Lina
    Shi, Zhongyi
    Qiu, Xingdong
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (03): : 747 - 755
  • [40] Impact of bone metastasis on prognosis in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
    Zhu, Yonghua
    She, Jingyao
    Sun, Rong
    Yan, Xinxin
    Huang, Xinyao
    Wang, Peijuan
    Li, Bo
    Sun, Xiangdong
    Wang, Changqing
    Jiang, Kai
    FRONTIERS IN IMMUNOLOGY, 2024, 15